NCT01664988

Brief Summary

Gestational hypertension is the main cause of maternal and fetal mortality, however, it has no definite effective treatment. nowadays, the stress management approaches are use for essential hypertension. So, this study aimed is study the effect of progressive muscular relaxation and breathing control technique on blood pressure during pregnancy. this 3-groups clinical trial has been done in Mashhad Health Centers and Governmental hospitals. 60 pregnant women with systolic blood pressure less than 135 mm Hg or diastolic blood pressure more than 85 mm Hg who met inclusion criteria were assigned into three groups of progressive muscular relaxation, breathing control and control. In tow experiment groups, exercises were controlled by one day personally and the rest by CD, BP before and after interventions was controlled for 4 weeks. In control group blood pressure was measured before and after 15 minutes with no intervention.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Feb 2010

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2012

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 15, 2012

Completed
Last Updated

August 16, 2012

Status Verified

August 1, 2012

Enrollment Period

1.6 years

First QC Date

July 24, 2012

Last Update Submit

August 15, 2012

Conditions

Outcome Measures

Primary Outcomes (2)

  • effect of muscular relaxation

    effect of muscular relaxation by check of the blood pressure after muscular relaxation was controlled

    up to1 month

  • decrease blood pressure

    up to 1 month

Secondary Outcomes (1)

  • time of decreasing blood pressure

    up to 1 month

Study Arms (3)

muscular relaxation

EXPERIMENTAL

muscular relaxation was done using Jacobson by contracting and relaxing selected groups of muscles until total relaxation

Behavioral: muscular relaxation

breath control

EXPERIMENTAL

include deep diaphragmatic breathing and decrease breath rate to 6-10/min

Behavioral: breath control

control

OTHER

received routine care of clinic or health center and control their blood pressure weekly and use drugs if necessary

Other: control (routine care)

Interventions

muscular relaxation was done using Jacobson by contracting and relaxing selected groups of muscles until total relaxation

Also known as: one
muscular relaxation
breath controlBEHAVIORAL

breathing control techniques include deep diaphragmatic breathing and decrease breath rate to 6-10/min

Also known as: two
breath control

received routine care of clinic or health center and use drugs if necessary

Also known as: 3
control

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • systolic blood pressure ≥ 135mmHg or
  • diastolic blood pressure ≥ 85mmHg
  • absence of severe preeclampsia condition
  • eclampsia
  • absence chronic hypertension
  • gestational age 20-36w
  • single pregnancy
  • have not contraction or bleeding
  • absence of underlying disease and mental disorders
  • absence of polihydramnios
  • hydatiform mole and placenta previa
  • not addicted to drugs, alcohol, mood-altering medicine and cigarette
  • not to use similar relaxation methods and breathing techniques during pregnancy
  • reading and writing literacy
  • have contact number

You may not qualify if:

  • using antihypertensive drugs(for experimental groups)
  • CBR
  • bleeding
  • contraction or watering during study
  • deteriorating of preeclampsia to severe form
  • hospitalization
  • start medical treatment for experiment groups
  • changing mind for continuing with study
  • to be absent in one session of personal instruction for experiment groups do not exercises more than 3 sessions of relaxation and breathing control at home
  • delivery during 4- week interventions and presence of symptoms such as confusion, fatigue, feeling of suffocation, pain, blurred vision during doing exercises

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
researcher

Study Record Dates

First Submitted

July 24, 2012

First Posted

August 15, 2012

Study Start

February 1, 2010

Primary Completion

September 1, 2011

Study Completion

February 1, 2012

Last Updated

August 16, 2012

Record last verified: 2012-08